Ochsner Cancer Institute

07/29/2026

At Ochsner MD Anderson Cancer Center, physicians are leading national research collaborations, early-phase clinical trials, genetic screening initiatives and cellular therapy programs that are improving outcomes for current patients while paving the way for future treatment innovations.

Learn more about advanced cellular therapies, genetic testing and clinical trials available to patients across Louisiana:

Guided by a commitment to compassionate care, innovation and discovery, Ochsner MD Anderson Cancer Center provides patients across south Louisiana access to world-class cancer treatments close to home.

07/28/2026

In October 2024, Michelle A.'s annual mammogram revealed early-stage breast cancer.

She shares how integrative oncology services at Ochsner MD Anderson Cancer Center – Baton Rouge helped her through treatment, reclaiming her health and prioritizing her well-being in ways she never had before.

Watch Michelle's full story: https://youtu.be/5uztN8z0Gcc

07/27/2026

Immunotherapy is a cancer treatment that uses a person's own immune system to find and destroy cancer cells.

Learn from Ochsner MD Anderson oncologist Daniel Johnson, MD, about advanced immunotherapy treatments available at Ochsner, including T-cell therapies, clinical trials and the future of cancer immunotherapy, in this episode of "Cancer Immunotherapy: Decoded."

"Decoded," a podcast by Ochsner Health, explores groundbreaking medical innovations and technology. Listen on your favorite streaming platform or watch now: https://ow.ly/AJbl50ZqPOt

07/23/2026

Integrative oncology is a branch of cancer care that focuses on symptom management. The integrative oncology program at Ochsner MD Anderson Cancer Center is designed to support a patient's overall well-being and promote a high quality of life both during and after treatment.

Integrative oncology services we offer include:
• occupational therapy
• therapeutic yoga
• nutrition
• art therapy
• acupuncture

Courtney Bozant, NP, at Ochsner MD Anderson Cancer Center at Ochsner Cancer Center – Baton Rouge, said oncologists, support staff, social workers and dietitians work directly with each other to provide individualized care plans for each patient.

"We are all so closely interlinked and have great communication with each other that it just creates a very good home base for our patients," she said.

Learn more about integrative oncology services at Ochsner MD Anderson Cancer Center: https://ow.ly/XNOM50ZqPNh

07/21/2026

Ochsner MD Anderson Cancer Center's Center for Innovative Cancer Therapies program is the only phase 1 clinical trials program between Houston and Birmingham.

This program allows us to get patients access to leading-edge treatments before they are widely available.

Hear from Ochsner MD Anderson oncologist Marc Matrana, MD, about how precision medicine is advancing cancer research.

Learn more about precision medicine at Ochsner: https://ow.ly/APSH50ZqPCI

07/10/2026

The Lieselotte Tansey Breast Cancer Center at Ochsner MD Anderson Cancer Center and Ochsner MD Anderson Cancer Center at St. Tammany Cancer Center – A campus of Ochsner Medical Center, have again received accreditation under the American College of Surgeons (ACS) National Accreditation Program for Breast Center (NAPBC).

Programs accredited by NAPBC follow a model for organizing and managing a breast center to facilitate multidisciplinary, integrated, and comprehensive breast cancer services.

Ochsner MD Anderson and the Lieselotte Tansey Breast Cancer Center also become an ACS Surgical Quality Partner. This designation lets patients know Ochsner MD Anderson and the Lieselotte Tansey Breast Cancer Center are dedicated to quality and relentless self-improvement.

"ACS Quality programs are grounded in more than a century of experience and participation is an important measure of a hospital’s surgical quality," said ACS Executive Director & Chief Executive Officer Patricia L. Turner, MD, MBA, FACS. "As an ACS Surgical Quality Partner, Ochsner MD Anderson has shown a commitment to providing the best possible patient care, evaluating that care in a rigorous fashion, and dedicating themselves to continuous self-improvement."

Learn more about the Lieselotte Tansey Breast Cancer Center:https://www.ochsner.org/locations/lieselotte-tansey-breast-center-at-ochsner/

Learn more about St. Tammany Cancer Center: https://www.ochsner.org/locations/st-tammany-cancer-center-a-campus-of-ochsner-medical-center/

07/09/2026

Eight Ochsner MD Anderson Cancer Center locations have again received accreditation from the American College of Surgeons (ACS) Commission on Cancer (CoC) Accreditation Program.

This recognition highlights our ongoing commitment to providing high-quality cancer care and support to our patients and communities. Locations include:

• The Gayle and Tom Benson Cancer Center at Ochsner Medical Center
• Ochsner Baptist - A Campus of Ochsner Medical Center
• Ochsner Medical Center - Kenner
• Ochsner Medical Center - West Bank Campus
• Ochsner Cancer Center - Baton Rouge
• Ochsner Medical Complex - The Grove
• Slidell Regional Cancer Center - A Campus of Ochsner Medical Center
• St. Tammany Cancer Center - A Campus of Ochsner Medical Center

CoC accreditation is granted to institutions committed to providing high-quality cancer care. Each cancer program must undergo a rigorous evaluation and review of its performance and compliance with CoC standards.

"Patients and families can look at these accreditations and recognition as markers of a cancer program committed to meeting and exceeding nationally recognized standards and continuously enhancing the care experience in their own community, close to home,” said Zoe Larned, MD, director, Ochsner MD Anderson Cancer Center and system chair, hematology/oncology, Ochsner Health.

Thank you to our teams for your dedication to patient care and excellence!

Learn more: https://ow.ly/NETb50Zm9zv

07/08/2026

Ochsner MD Anderson Cancer Center is the first cancer center in the South to offer Biology-guided Radiotherapy (BgRT), a technology that tracks tumors in real time during radiation treatment.

Most radiation therapy relies on static images taken before treatment begins. BgRT is different. Using PET imaging combined with a linear accelerator, the RefleXion platform continuously adjusts the radiation beam to follow tumor movement, whether from breathing or other normal body activity.

The result is more precise targeting, less damage to healthy tissue and a better experience for patients.

Currently FDA-approved for patients over 21 with specific bone and lung cancers, the technology also opens the door for future clinical trials, including treatment for neurological tumors and prostate cancers.

Learn more: https://www.nola.com/entertainment_life/louisiana_health/new-cancer-radiation-tech-at-new-orleans-hospital/article_917e68cf-9c56-4a28-a2be-476a36cdb3c7.html

"Less recurrence. More cure. Less side effects. Better patient experience," said Dr. Christophe Marques, a radiation oncologist with Ochsner Health.

07/06/2026

The five-year cancer survivor rate in the United States is now 70%. As the survivor population grows, cancer centers are evolving their care models to ensure ongoing support for patients as they move beyond active treatment.

At Ochsner MD Anderson Cancer Center, our team is expanding the role of advanced practice providers (APPs) to lead survivorship visits, develop personalized care plans and provide consistent follow-up.

Erica Doubleday, NP, director of Advanced Practice Providers at Ochsner MD Anderson, said cancer survivors value clarity, accessibility and continuity.

"Our model emphasizes multidisciplinary collaboration — integrating oncology, primary care, behavioral health and supportive services — to address not only surveillance, but also the long-term physical and psychosocial effects of cancer," she said. "We are increasingly standardizing survivorship care plans, embedding symptom management and psychosocial support, and strengthening collaboration with cardio-oncology, integrative oncology, women’s wellness and more to ensure long-term follow-up is both accessible and comprehensive."

Learn more: https://ow.ly/pfvI50ZkKsK

06/26/2026

Just 13 days after she joined Ochsner Health as a security officer, Kimberly H. was diagnosed with Stage 3 triple negative breast cancer — one of the most aggressive forms of the disease.

Her journey took a hopeful turn at Ochsner MD Anderson Cancer Center.

"I don't know if y'all have ever heard that saying, 'The Lord put you at the right place at the right time,'" Kimberly said. "Well, Ochsner had just started a study for triple negative breast cancer patients."

Under the expert care of hematologist oncologist Lingling Du, MD, Kimberly participated in a groundbreaking clinical trial that combined chemotherapy with advanced immunotherapy. This innovative treatment played a key role in her remarkable journey from diagnosis to becoming cancer-free.

Ochsner's Center for Innovative Cancer Therapies program is the only phase 1 clinical trials program between Houston and Birmingham.

Learn more about Ochsner MD Anderson Cancer Center at https://ow.ly/yKzQ50ZhH5a